IL161725A0 - A process for preparing an anthrax protective antigen - Google Patents

A process for preparing an anthrax protective antigen

Info

Publication number
IL161725A0
IL161725A0 IL16172501A IL16172501A IL161725A0 IL 161725 A0 IL161725 A0 IL 161725A0 IL 16172501 A IL16172501 A IL 16172501A IL 16172501 A IL16172501 A IL 16172501A IL 161725 A0 IL161725 A0 IL 161725A0
Authority
IL
Israel
Prior art keywords
cells
coli
preparing
followed
protective antigen
Prior art date
Application number
IL16172501A
Other languages
English (en)
Original Assignee
Rakesh Bhatnagar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rakesh Bhatnagar filed Critical Rakesh Bhatnagar
Publication of IL161725A0 publication Critical patent/IL161725A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Laminated Bodies (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
IL16172501A 2001-11-05 2001-12-07 A process for preparing an anthrax protective antigen IL161725A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1127DE2001 IN190590B (pt) 2001-11-05 2001-11-05
PCT/IN2001/000215 WO2003040179A1 (en) 2001-11-05 2001-12-07 High level constitutive production of anthrax protective antigen

Publications (1)

Publication Number Publication Date
IL161725A0 true IL161725A0 (en) 2005-11-20

Family

ID=11097131

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16172501A IL161725A0 (en) 2001-11-05 2001-12-07 A process for preparing an anthrax protective antigen

Country Status (16)

Country Link
US (1) US7329513B2 (pt)
EP (1) EP1442052B1 (pt)
JP (1) JP2005510215A (pt)
CN (1) CN100347189C (pt)
AT (1) ATE484517T1 (pt)
BR (1) BRPI0117173A2 (pt)
CA (1) CA2465679A1 (pt)
DE (1) DE60143276D1 (pt)
HK (1) HK1072610A1 (pt)
IL (1) IL161725A0 (pt)
IN (1) IN190590B (pt)
MX (1) MXPA04004281A (pt)
RU (1) RU2288272C2 (pt)
UA (1) UA80809C2 (pt)
WO (1) WO2003040179A1 (pt)
ZA (1) ZA200403396B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
ES2427641T3 (es) 2003-05-22 2013-10-31 Ibio, Inc. Molécula vehículo recombinante para la expresión, el suministro y la purificación de polipéptidos diana
AU2003271835A1 (en) * 2003-06-06 2005-01-04 Avecia Limited Process for the separation of proteins
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
US8101735B2 (en) 2004-06-16 2012-01-24 Health Protection Agency Preparation of protective antigen
CN100336908C (zh) * 2004-09-10 2007-09-12 中国人民解放军军事医学科学院微生物流行病研究所 一种制备重组炭疽保护性抗原的方法及其专用表达质粒
CA2616859C (en) 2005-08-03 2015-04-14 Fraunhofer Usa, Inc. Compositions and methods for production of immunoglobulins
EP1984405A4 (en) 2006-02-13 2010-06-30 Fraunhofer Usa Inc INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
WO2008048344A2 (en) * 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
CA2651962A1 (en) * 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Anthrax compositions and methods of use and production
WO2008115198A2 (en) 2006-06-30 2008-09-25 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates,synthesis and uses thereof
US8420607B2 (en) 2006-06-30 2013-04-16 University Of Georgia Research Foundation, Inc. Anthrax carbohydrates, synthesis and uses thereof
CA2692933C (en) 2007-07-11 2016-10-18 Fraunhofer Usa, Inc. Yersinia pestis antigens, vaccine compositions, and related methods
WO2009126355A2 (en) * 2008-01-28 2009-10-15 Baxter International, Inc. Methods of increasing recombinant production of bacillus anthracis protective antigen
US8734803B2 (en) 2008-09-28 2014-05-27 Ibio Inc. Humanized neuraminidase antibody and methods of use thereof
EP2344188B1 (en) 2008-10-02 2017-02-15 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
US20100183675A1 (en) * 2009-01-22 2010-07-22 Allan Watkinson Stable vaccine compositions and methods of use
CA2776144C (en) 2009-09-29 2020-10-27 Fraunhofer Usa, Inc. Influenza hemagglutinin antibodies, compositions, and related methods
US20120301951A1 (en) * 2010-11-18 2012-11-29 E. I. Du Pont De Nemours And Company Prevention of contamination of nutrient feed reservoirs & feed lines in bioreactor systems
RU2633504C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E.coli - продуцент полноразмерного протективного антигена Bacillus anthracis в форме вирусоподобных частиц
RU2633508C1 (ru) * 2016-12-27 2017-10-12 Федеральное государственное учреждение "Федеральный исследовательский центр "Фундаментальные основы биотехнологии" Российской академии наук (ФИЦ Биотехнологии РАН) Штамм E. coli - продуцент изолированного домена 1 протективного антигена Bacillus anthracis в форме вирусоподобных частиц
CN115125224B (zh) * 2022-08-11 2023-07-18 福州大学 一种可规模化生产具有活性的dna聚合酶的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800821A (en) * 1995-03-10 1998-09-01 New England Medical Center Hospitals, Inc. Bacterial spores as a heat stable vaccine delivery system
EP1068309B1 (en) * 1998-04-07 2004-12-15 Wisconsin Alumni Research Foundation Enterotoxin-deficient bacillus
US20020086032A1 (en) * 1999-02-02 2002-07-04 Mahan Michael J. Producing antibodies with attenuated bacteria with altered DNA adenine methylase activity
WO2003055977A2 (en) * 2001-10-01 2003-07-10 Regents Of The University Of California A method for generating overexpression of alleles in genes of unknown function
UA80809C2 (en) * 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
US7763451B2 (en) * 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines

Also Published As

Publication number Publication date
CN1582298A (zh) 2005-02-16
CN100347189C (zh) 2007-11-07
BRPI0117173A2 (pt) 2018-04-17
JP2005510215A (ja) 2005-04-21
IN190590B (pt) 2003-08-09
WO2003040179A1 (en) 2003-05-15
UA80809C2 (en) 2007-11-12
HK1072610A1 (en) 2005-09-02
ZA200403396B (en) 2005-08-05
DE60143276D1 (de) 2010-11-25
EP1442052A1 (en) 2004-08-04
US7329513B2 (en) 2008-02-12
US20050054038A1 (en) 2005-03-10
CA2465679A1 (en) 2003-05-15
RU2004117085A (ru) 2005-03-27
EP1442052B1 (en) 2010-10-13
MXPA04004281A (es) 2005-03-31
RU2288272C2 (ru) 2006-11-27
ATE484517T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
HK1072610A1 (en) High level constitutive production of anthrax protective antigen
CA1318867C (en) Plasmid expression vector for use in escherichia coli
CY1110494T1 (el) Μεταστροφες μεταβολικου ρυθμου σε ζυμωσεις που εκφραζουν ανασυνδυασμενες πρωτεϊνες
NZ335628A (en) Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
EP0737747A3 (de) Cytoplasmatische Expression von Antikörpern, Antikörperfragmenten und Antikörperfragment-Fusionsmolekülen in E. coli
Saunders et al. Heterologous gene expression in filamentous fungi
IL173474A0 (en) Methods for producing recombinant proteins
CN102533839B (zh) 融合表达含有二硫键蛋白质的方法
WO2007015691A3 (en) Methods and compositions for increasing longevity and protein yield from a cell culture
JP5662363B2 (ja) 難発現性タンパク質の分泌のためのタンパク質融合因子（ｔｆｐ）を明らかにする方法、タンパク質融合因子（ｔｆｐ）ライブラリーを製造する方法、及び難発現性タンパク質の組み換え的生産方法
CN102659928A (zh) 一种人工合成的信号肽及其应用
KR100614020B1 (ko) 폴리펩티드의 재조합 생산을 위한 향상된 방법
Kawasaki et al. Folding-Dependentin VitroProtein Splicing of theSaccharomyces cerevisiae VMA1Protozyme
Maleki et al. High expression of methylotrophic yeast-derived recombinant human erythropoietin in a pH-controlled batch system
CN101921315B (zh) 一种人工合成的信号肽及其应用
JP2540039B2 (ja) プラスミドベクタ−
AU1093597A (en) Vector for expression of n-terminally extended proteins in yeast cell
CN104846001B (zh) 一种外源蛋白原核分泌表达系统及其应用
CA2082802C (en) Method for expressing polypeptides in cyanobacteria
CN107384934A (zh) 重组人干扰素α2b的制备方法
KR100798894B1 (ko) 재조합단백질 생산용 단백질융합인자
Kunes et al. Expression of antibodies using single‐open reading frame vector design and polyprotein processing from mammalian cells
AU696454B2 (en) Family of peptides known as xenoxins
Schendel Overview of Protein Expression in E. coli
Bahrami et al. Production of recombinant human granulocyte-colony stimulating factor by Pichia pastoris